IMARC Group, a leading market research company, has recently releases report titled “Postoperative Pain Therapeutics Market Report by Drug Class (Opioids, NSAIDs, Local Anesthetics, Tricyclic Antidepressants, Antiepileptic Drugs, and Others), Route of Administration (Oral, Intravenous, Intramuscular, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Region 2024-2032”, Offers a comprehensive analysis of the industry, which comprises insights on the postoperative pain therapeutics market share.
How Big Is the Postoperative Pain Therapeutics Market?
The global postoperative pain therapeutics market size reached US$ 13.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 20.9 Billion by 2032, exhibiting a growth rate (CAGR) of 4.86% during 2024-2032.
Factors Affecting the Growth of the Postoperative Pain Therapeutics Industry:
- Increasing Surgical Procedures Worldwide:
The postoperative pain therapeutics market is experiencing substantial growth, driven by the increasing number of surgical procedures globally. As medical advancements make surgeries safer and more accessible, the demand for effective postoperative pain management solutions escalates. This rise in surgical interventions, ranging from minimally invasive surgeries to major operations, directly impacts the market size, as there is a growing need to address the pain associated with post-surgical recovery. Market analysis indicates that as healthcare systems are expanding their surgical capabilities, the demand for postoperative pain therapeutics is rising, contributing to market growth and influencing market share among pharmaceutical companies specializing in pain management solutions.
- Advancements in Pain Management Therapeutics:
The market is significantly propelled by advancements in pain management therapeutics, including the development of novel non-opioid medications and targeted drug delivery systems. Additionally, innovations in pharmacological research are leading to the introduction of new therapies that offer effective pain relief with reduced side effects and lower risk of dependency. These advancements improve patient outcomes and also align with the growing emphasis on safer pain management practices. Market trends suggest that as healthcare providers and patients seek alternatives to traditional opioids, the market for advanced postoperative pain therapeutics is expanding, driving market growth and reshaping treatment protocols in post-surgical care.
- Growing Awareness and Patient Advocacy:
The increasing awareness and advocacy for better pain management in postoperative care play a crucial role in driving the market. Patients and healthcare professionals are becoming more informed about the importance of effective pain control in enhancing recovery and reducing the risk of complications after surgery. This accelerating awareness is fostering a demand for innovative and effective pain management solutions, influencing market trends towards adopting multimodal pain management strategies. Market analysis highlights that this shift towards prioritizing patient comfort and recovery outcomes is driving market growth, as stakeholders across the healthcare spectrum advocate for improved postoperative pain management practices, thereby influencing market outlook and the development of new therapeutic options.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/postoperative-pain-therapeutics-market/requestsample
Leading Companies Operating in the Global Postoperative Pain Therapeutics Industry:
- Heron Therapeutics
- Mallinckrodt Pharmaceuticals
- Pacira BioSciences, Inc.
- Pfizer, Inc.
- Trevena, Inc
Postoperative Pain Therapeutics Market Report Segmentation:
Breakup by Drug Class:
- Opioids
- NSAIDs
- Local Anesthetics
- Tricyclic Antidepressants
- Antiepileptic Drugs
- Others
Opioids represent the largest segment due to their potent analgesic properties and widespread use in managing moderate to severe postoperative pain, despite growing concerns over dependency and side effects.
Breakup by Route of Administration:
- Oral
- Intravenous
- Intramuscular
- Others
Oral represents the largest segment as it is the most convenient and preferred method for pain management post-surgery, allowing for easy dosing and patient compliance.
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
Hospital pharmacies represent the largest segment, attributed to the immediate need for postoperative pain management medications in hospital settings, where surgeries are performed and initial pain management protocols are established.
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
North America is the largest market, driven by its advanced healthcare infrastructure, high volume of surgical procedures, and the presence of key pharmaceutical companies focused on the development and marketing of pain management therapeutics.
Global Postoperative Pain Therapeutics Market Trends:
The postoperative pain therapeutics market is witnessing a shift towards multimodal pain management, a trend driven by the goal of enhancing pain relief while minimizing opioid use and its associated risks. This approach combines various pharmacological and non-pharmacological therapies to achieve better pain control and patient outcomes.
Additionally, there is a growing emphasis on personalized medicine in pain management, leveraging genetic insights to tailor pain therapy to individual patient needs, improving efficacy, and reducing side effects. The market is also witnessing an increase in the development and use of long-acting local anesthetics and non-addictive painkillers, reflecting a concerted effort to address postoperative pain more effectively and safely.
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
